Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP716740.RA1Mr5gXggh2vTDwT83QlczHopm_MaQ_TCsXqrx6PBmxE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP716740.RA1Mr5gXggh2vTDwT83QlczHopm_MaQ_TCsXqrx6PBmxE130_assertion type Assertion NP716740.RA1Mr5gXggh2vTDwT83QlczHopm_MaQ_TCsXqrx6PBmxE130_head.
- NP716740.RA1Mr5gXggh2vTDwT83QlczHopm_MaQ_TCsXqrx6PBmxE130_assertion description "[RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP716740.RA1Mr5gXggh2vTDwT83QlczHopm_MaQ_TCsXqrx6PBmxE130_provenance.
- NP716740.RA1Mr5gXggh2vTDwT83QlczHopm_MaQ_TCsXqrx6PBmxE130_assertion evidence source_evidence_literature NP716740.RA1Mr5gXggh2vTDwT83QlczHopm_MaQ_TCsXqrx6PBmxE130_provenance.
- NP716740.RA1Mr5gXggh2vTDwT83QlczHopm_MaQ_TCsXqrx6PBmxE130_assertion SIO_000772 24098947 NP716740.RA1Mr5gXggh2vTDwT83QlczHopm_MaQ_TCsXqrx6PBmxE130_provenance.
- NP716740.RA1Mr5gXggh2vTDwT83QlczHopm_MaQ_TCsXqrx6PBmxE130_assertion wasDerivedFrom befree-20150227 NP716740.RA1Mr5gXggh2vTDwT83QlczHopm_MaQ_TCsXqrx6PBmxE130_provenance.
- NP716740.RA1Mr5gXggh2vTDwT83QlczHopm_MaQ_TCsXqrx6PBmxE130_assertion wasGeneratedBy ECO_0000203 NP716740.RA1Mr5gXggh2vTDwT83QlczHopm_MaQ_TCsXqrx6PBmxE130_provenance.